Temozolomide in Relapsed or Advanced Anaplastic Oligodendroglioma and Oligoastrocytoma: Single-arm, Phase II Trial

Mise à jour : Il y a 4 ans
Référence : NCT01847235

Femme et Homme

Extrait

The purpose of this study is to determine the efficacy and safety of temozolomide in patient with relapsed or advanced anaplastic oligodendroglioma and anaplastic oligoastrocytoma.


Critère d'inclusion

  • Anaplastic Oligodendroglioma ,Anaplastic Oligoastrocytoma

Liens